Abstract
Therapy testing on man is as old as medicine itself. In honor of this, Article 15 of the Code of Medical Ethics, in no uncertain terms, requires doctors to “ensure the regularity of… biomedical research.” Alzheimer’s disease, a form of senile dementia and a biological enigma affecting more than 400,000 persons in France, remains a challenge to experimental medicine (LaRevue du Practicien, 1995). For French specialists, neurologists and gerontologists, THA (Tetrahydroaminoacrinine or tacrine) appeared to be a possible therapy, leading to an administrative marketing permit in April, 1994 (La Presse médicale, 1995). At present, the “best candidates” for tacrine are notably “those who are in a position to be included in research protocols for more efficient and tolerated medicine” (Derouesne, (1994); LaRevue du Practicien, 1994).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Article L 209–9 (1988): Before proceeding with any research on human beings, all investigators are obligated to submit a project to this committee. In: Conditions of Consent, December 20.
Assemblée Nationale (Charles M): This analysis is based on the interpretation of the law of the House of Representatives according to whom the law embraces “research (diagnostic, therapeutic and preventative research) including the examination of medical substances, as well as research linked with all new surgical technics”.
Beaudoin J-L and Parizeau M-H (1987): Legal and Ethic Reflections Concerning Consent to Medical Treatment, Medicine-Science 3: 8–12.
Bick C (1983): Concerning European case law. Medical Research and Human Rights, the European approach. JPC 1:3719.
Bouvenet G, and Eschwege E (1994): Therapy Testing and Informed Consent - Methodological Bases, Legal and Ethical Aspects. La Revue du Practicien Vol. 44:2767–9.
Bouvier F (1986): An opinion relating to “Ethical Problems Raised by the Testing of New Treatments on Men” In: Consent to Therapy: Realities and Perspectives, J C P 1:3249.
Code of Public Health (1990): The application decree N° 90–872 dated September 27, 1990, introduced in the regulations section a book II b entitled “Protection of Individuals Volunteering for Biomedical Research”.
COGNEXTM (1994): This document signed on September 9, 1994 by the directors of social security of hospitals and health, outlines the mode of prescriptions and the pharmacological oversight of COGNEX, one of the first medicines with a degree of efficiency in treating Alzheimer’s disease.
Commission, (1979): X versus Austria. December 13, N° 8278–78.
Derouesne C, (1994): Which kind of patients with Alzheimer’s disease can be treated and how? Reply to V. Lemaire’s note In: Le Concours Médical, September 17, pp. 2392–2393.
Duprat J-P (1982): Information and Consent of the Patient in the Case of Tests of Medicine on Humans. RTDSS:369.
European Convention of Human Rights Commission (1983): establishes the prohibition to submitting of an individual to inhumane or degrading treatment. Article 3 March 2, N° 9974/82: D.R. 32:292.
Fagot-Largeault A (1994): Informed Consent, Medicine and Law, N° 6, May-June, pp. 55–56.
Jasmin C (1991): Bioethics and Therapeutic Research: Informed Consent, Médecine-Science May, N°5, Vol.7: p. 473.
La Documentationfrançaise (1988): Documentary notes and studies. -5, N°.4855:23.
La Presse médicale (1995): This substance, commercialized under the tradename COGNEX was previously only available in the United States. February 4, N° 5, pp. 285.
La Revue du Practicien (1994): Coverage Forms for Alzheimer’s Patients. September 26, pp. 17–20.
La Revue du Practicien (1995): This neurological degenerative complaint is characterized notably by the appearance of problems of memory, personality and language. December 18, pp. 7–70.
Labbée X (1995): Medical Experimentation,Médecine et Droit N° 11:10–15.
Litec (1993): Biomedical Research on Man: Medical and Hospital-Related Law. 5-, Fasc. 34:3.
Maurain C and Viala G (1985): On the difficulty of a right to therapeutic information: Legal Limits of Therapeutic Information. JPC I:3203.
Montador J (1971): The absence of Consent and Hospital Public Service’s Responsibility, RTDSS: 180–191.
Nuremberg Code (1949):.”It is absolutely necessary to obtain the voluntary consent of the patient…For the duration of the tests, the volunteer patient will have the right to decide to stop the tests if these cause him mental or physical discomfort and if, in any other manner, the continuation of the tests seems impossible to him”. In: United States vs Karl Brandt et al.
Parizeau M H (1988): Randomization, double blinds, placebos or reference medicine In: The Concept of Consent to Human Experimentation, doctorate of philosophy thesis, University Paris XII
Roy D J (1986): Medical and Research Practices; North-American Perspectives on Consent. Medicine and Hygiene 44:2014–2017.
Sabatini J (1990): From Absence of Consent to Tape of a Person. Rev Prat. 40:935–936.
Thouvenin D (1985): Human Experimentation: on the Concept of Informed Consent, Technical Culture, November, N° 15:109.
Thouvenin D (1988): The Reference to the Care Contract in Experimentation on Humans, In: Medical Ethics and Human Rights, Actes Sud-Inserm: 123–146.
Woodward W (1979): Informed consent of volunteers: a direct measurement of comprehension and retention of information, Clinical research 27:248.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Birkhäuser Boston
About this chapter
Cite this chapter
Garay, A. (1997). Legal Issues in Alzheimer Disease Research in France. In: Becker, R.E., Giacobini, E., Barton, J.M., Brown, M. (eds) Alzheimer Disease. Advances in Alzheimer Disease Therapy. Birkhäuser Boston. https://doi.org/10.1007/978-1-4612-4116-4_82
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4116-4_82
Publisher Name: Birkhäuser Boston
Print ISBN: 978-1-4612-8660-8
Online ISBN: 978-1-4612-4116-4
eBook Packages: Springer Book Archive